Skip to main content
. Author manuscript; available in PMC: 2013 Jun 21.
Published in final edited form as: Oncogene. 2008 Oct 6;27(45):5904–5912. doi: 10.1038/onc.2008.271

Figure 3.

Figure 3

Tumors recruit MSC from the bone marrow by means of tumor-derived soluble factors. Immature myeloid cells migrate to lymph nodes, where DC cross-prime T cells, and interfere with this process. They also migrate to the tumor site and become tumor-associated MSC, which are adept in blocking T cell functions through the production of arginase I and activation of iNOs.